Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.09 USD
Change Today -0.17 / -3.23%
Volume 252.4K
OCAT On Other Exchanges
Symbol
Exchange
NASDAQ GM
Stuttgart
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert Kaufmann M.D.

Member of Ethics Advisory Board, Ocata Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Robert Kaufmann MD is subspecialty board certified in Reproductive Endocrinology and Infertility by the American Board of Obstetrics and Gynecology. Prior to joining Dallas Fort Worth Fertility Associates in Fort Worth, Texas, Dr. Kaufmann served as Division Head for Medical University of South Carolina’s Department of Reproductive Endocrinology in Charleston. Dr. Kaufmann serves as Member of Ethics Advisory Board of Advanced Cell Technology Inc. Dr. Kaufmann holds a ...

Read Full Background

Corporate Headquarters*

33 Locke Drive
Marlborough, Massachusetts 01752

United States

Phone: 508-756-1212
Fax: 508-229-2333

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCAT:US $5.09 USD -0.17

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$884.3K
Olav Hellebo Chief Executive Officer and Director
ReNeuron Group plc
--
Martin M. McGlynn Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc
StemCells Inc.
$789.5K
I. Richard Garr J.D.Co-Founder, Chief Executive Officer, President, General Counsel and Director
Neuralstem, Inc.
$651.2K
Keith Murphy Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee
Organovo Holdings, Inc.
$362.9K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OCATA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.